Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.Moderna is one of two drugmakers that announced on Thursday the full results of a closely watched trial of an experimental vaccine given to patients with melanoma.